v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Revenue $ 55,929 $ 59,191
Cost of revenue:    
Cost of revenue exclusive of amortization 9,355 10,141
Amortization 4,924 5,290
Gross profit 41,650 43,760
Operating expenses:    
Sales and marketing 19,578 20,653
Product development 6,499 9,301
General and administrative 12,084 12,269
Depreciation and amortization 8,325 8,527
Transaction, integration and restructuring expenses (765) 1,265
Goodwill impairment 197,219 176,531
Total operating expenses 242,940 228,546
Loss from operations (201,290) (184,786)
Other income (expense), net:    
Interest income 1,297 2,052
Interest expense (2,629) (2,433)
Gain on remeasurement of Tax Receivable Agreement liability 6,521 20,664
Loss on partial extinguishment of debt 0 (507)
Other income (expense), net 312 (969)
Total other income, net 5,501 18,807
Net loss before income taxes (195,789) (165,979)
Benefit from income taxes 3,435 10,886
Net loss (192,354) (155,093)
Less: Net loss attributable to noncontrolling interests (53,733) (47,865)
Net loss attributable to Definitive Healthcare Corp. $ (138,621) $ (107,228)
Net loss per share of Class A common stock:    
Basic $ (1.32) $ (0.95)
Diluted $ (1.32) $ (0.95)
Weighted average Class A common stock outstanding:    
Basic 104,675,068 112,782,505
Diluted 104,675,068 112,782,505